Helicobacter pylori have infected nearly half of the world’s population. In the developing countries, more than 90% of adults are typically infected during their early childhood, and once acquired the infection would last for several decades (
1).
Helicobacter pylori infection is the main cause of gastritis and persistent chronic inflammation may lead to peptic ulcers or gastric cancer (
2-
4).
Helicobacter pylori gastritis is associated with the expression of various cytokines and immune cells infiltration (
1). It is recently demonstrated that IL-17, IL-8 and IL-18 are associated with
H. pylori-related gastritis diseases (
5-
7). Recently, it is found that IL-17, a pro-inflammatory cytokine that can recruit neutrophils by inducing the production of CXC chemokines, plays a vital role in the inflammatory response to the
H. pylori-related diseases (
8). Furthermore, it is also reported that IL-17, IL-8, and IL-18 are important to maintain the chronic gastric inflammation in the Mongolian gerbils model induced by the
H. pylori (
8-
10). Considering that up-regulation of IL-17, IL-8 and IL-18 plays a crucial role in
H. pylori infection, it was explored that the expression of IL-17, IL-8 and IL-18 in peripheral blood may be involved in the inflammatory response to
H. pylori.